Rising UTI Prevalence Driving Urological Surgery Instrument Demand

Around the world, 40–60% of the women suffer from a urinary tract infection (UTI) at least once. Similarly, for every 100,000 men, around 14,000 suffer from this disease at some point in their lives. UTIs are caused by the colonization of the kidneys, bladder, ureters, and urethra by E. coli bacterium. Men and women both get UTIs, and some get them repeatedly. Although UTIs are commonly treated with antibiotics, if the infection happens due to a structural defect in the urinary tract, then surgery is required.

Therefore, the growing prevalence of complicated UTIs will be a key driver for the urology surgical instrument market in the coming years. Another factor behind the rising volume of urological surgeries is the rising incidence of prostate and bladder cancers, which, as per the World Cancer Research Fund, were diagnosed in 1,276,106 and 549,393 people, respectively, in 2018. Prostate is the second-most-common, while the bladder is the sixth-most-common site of cancer in men.

All these products are used for a variety of purposes in urological surgery, including urinary stones, chronic kidney disease (CKD), urinary incontinence and pelvic organ prolapse, oncology (cancer), benign prostatic hyperplasia (BPH), hernia, and erectile dysfunction (ED). Among these, CKD dominates the application segment of the urology surgical instrument market owing to its high incidence, which ranges from 11–13% of the total people in the world. The disease has common risk factors and causes, including diabetes, cardiovascular diseases (CVDs), tobacco smoking, recurring kidney infection (a kind of UTI), and obesity, apart from family history and ethnic predisposition.

Currently, much of this demand comes from North America, as it is home to the most-advanced healthcare system in the world. As a result, the number of hospitals and other medical centers conducting urological surgeries is increasing in the U.S. and Canada. Further, extensive research and development (R&D) has unearthed better surgical approaches for the treatment of the diseases of the urinary tract. Additionally, the region has several government-funded and private insurance plans, which make healthcare affordable.

Comments are closed.